EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders

Álvaro Sabater-Gárriz iD, José Joaquín Cerón, Pedro Montoya, Inmaculada Riquelme iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0308386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Álvaro Sabater-Gárriz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Balearic ASPACE Foundation, Marratxí, Spain. Hauptthemen laut MEDLINE: Cerebral Palsy, Saliva, Biomarkers, Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pain in people with cerebral palsy (CP) has been classically underestimated and poorly treated, particularly in individuals with impaired communication skills.

Objective

To analyze changes in different salivary metabolites and pain behavior scales after a painful procedure in adults with CP and adults with typical development.

Methods

Salivary levels of sTNF-α, sIgA, Cortisol, FRAP, ADA and Alpha Amylase, as well as 3 observational pain scales (Wong-Baker, Non-Communicating Adults Pain Checklist and Facial Action Coding System) were assessed before and after an intramuscular injection in 30 Individuals with CP and 30 healthy controls. Video recording of face expression was performed during the procedure for offline analysis.

Results

Pain in subjects with CP was higher than in healthy controls after the intramuscular injection as displayed by observational scales. sTNF-α experienced a significant post-stimulus increase in both groups and that increase shows a tendency to correlate with the observational scales scores. Other biomarkers classically associated with stress (cortisol, Alpha Amylase) remain stable. Conclusion sTNF-α might be a promising pain indicator. Further research using controlled painful stimuli of greater intensity and pain self-reports, would be necessary to better understand its use as a pain biomarker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral PalsySalivaBiomarkersPainTumor Necrosis Factor-alphaCommunication DisordersHumansMaleFemaleAdultYoung AdultHydrocortisonePain MeasurementVaccinesCase-Control Studies

Substanzen

BiomarkersTumor Necrosis Factor-alphaHydrocortisoneVaccines

Autor:innen und Institutionen

  • Balearic ASPACE Foundation, Marratxí, Spain.
  • Research Institute on Health Sciences (IUNICS-IdISBa), University of the Balearic Islands, Palma de Mallorca, Spain.
  • Department of Nursing and Physiotherapy, University of the Balearic Islands, Palma de Mallorca, Spain.
  • Interdisciplinary Laboratory of Clinical Analysis, Interlab-UMU, Regional Campus of International Excellence Campus Mare Nostrum, University of Murcia, Murcia, Spain.

ORCID-Profile: Álvaro Sabater-Gárriz, Inmaculada Riquelme

Förderung

  • Ministerio de Ciencia e Innovación

Zitieren

APA

Sabater-Gárriz, Á., Cerón, J. J., Montoya, P., & Riquelme, I. (2024). Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders. PLOS ONE. https://doi.org/10.1371/journal.pone.0308386

Vancouver

Sabater-Gárriz Á, Cerón JJ, Montoya P, Riquelme I. Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders. PLOS ONE. 2024. doi:10.1371/journal.pone.0308386

BibTeX
@article{SabaterGrriz2024,
  author = {Sabater-Gárriz, Álvaro and Cerón, José Joaquín and Montoya, Pedro and Riquelme, Inmaculada},
  title = {Potential use of salivary TNF-α as a vaccine-induced pain biomarker in people with cerebral palsy and communication disorders},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0308386}
}
Kostenlos starten →